发明名称 ENHANCEMENT OF ORAL BIOAVAILABILITY OF NON-EMULSIFIED FORMULATION OF PRODRUG ESTERS WITH LECITHIN
摘要 A method for enhancing the oral bioavailability of a prodrug ester by formulating the ester as non-emulsified formulation with lecithin; as well a s a pharmaceutical composition of at least one antibiotic and lecithin in a no n- emulsified formulation; a method of treating infections with the non- emulsified formulation, and a method for preparing tablets by direct compression of blends of drugs with lecithin are disclosed. Non-emulsified formulations include solids, tablets, capsules, lozenges, suspensions, elixi rs and solutions, and exclude emulsions, liposomes, lipid matrix systems and micro-emulsions. A suitable prodrug ester is a cephalosporin .szlig.-lactam antibiotic such as cefditoren pivoxil, and a suitable non-emulsified formulation is a solid formulation.
申请公布号 CA2449002(A1) 申请公布日期 2002.12.05
申请号 CA20022449002 申请日期 2002.05.28
申请人 TAP PHARMACEUTICAL PRODUCTS INC. 发明人 BRINKER, DALE;BRISKIN, JACQUELINE;GUPTA, PRAMOD;VISHWASRAO, DILIP;APONTE, ROBERTO;TANEJA, RAJNEESH
分类号 A61K9/10;A61K9/00;A61K9/16;A61K9/20;A61K31/343;A61K31/4375;A61K31/545;A61K31/546;A61K31/56;A61K31/65;A61K31/7048;A61K45/00;A61K47/02;A61K47/24;A61K47/26;A61K47/36;A61P31/04;A61P43/00;(IPC1-7):A61K9/20;A61K9/14 主分类号 A61K9/10
代理机构 代理人
主权项
地址